Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.China Sky One Medical raises $25 million in private placement
The warrants have an exercise price of $12.50 per share and a term of 3 years.
The warrants have an exercise price of $12.50 per share and a term of 3 years.
The Treanda NDA for relapsed indolent NHL is supported by three studies in patients with NHL, including two single-agent studies and one in combination with rituximab. In these
According to USAMRIID scientists, animal studies to test the efficacy of these nanoviricides drug candidates against Ebola infection will be undertaken shortly. It is hoped that success against
The collaboration will evaluate Celera’s numerous genetic findings in liver diseases, including the Cirrhosis Risk Score, in the Geisinger bank of more than 600 liver tissue and blood
The biomarker study will enroll approximately 12 patients with stable schizophrenia who are receiving atypical antipsychotic therapy. Subjects will be randomized to receive MEM 3454 and placebo in
Accordingly, CytoPharm, the company’s partner in Taiwan, will fund and conduct a clinical trial of 144 chronic hepatitis C patients in Taiwan. The patients will receive one of
The Zegerid products were developed by Santarus and are the first and only immediate-release oral proton pump inhibitors (PPIs) commercialized in the US. Zegerid (omeprazole/sodium bicarbonate) capsules and
Attental has been proven in a randomized, double-blind, placebo controlled clinical trial to better overall motor performance and improve reading and spelling in children. The clinical trial demonstrated
Novartis and Ablynx are collaborating to discover and develop therapeutic Nanobodies for a range of disease areas, against a number of targets that are difficult to address with
As of the expiration of the subsequent offering period, Rocket Acquisition Corporation, a wholly-owned subsidiary of Roche, had purchased a total of approximately 34.54 million shares of Ventana